For research use only. Not for therapeutic Use.
JS399-19 (Cat No.: I012540) is a novel small molecule candidate under investigation for potential anticancer properties. Preliminary research suggests it interferes with key cellular signaling pathways, inhibiting tumor growth and proliferation. By targeting specific enzymes or receptors, JS399-19 may reduce disease progression in preclinical models. Ongoing studies focus on its pharmacokinetic profile, toxicity, and therapeutic efficacy in various tumor types. If successful, this compound could pave the way for advanced cancer therapies, addressing unmet medical needs and improving patient outcomes in clinical settings.
| CAS Number | 39491-78-6 |
| Synonyms | 3-Amino-2-cyano-3-phenylancrylic acid ethyl ester; 2-cyano-3-amino-3-phenylancryic acetate; Ethyl (Z)-3-amino-2-cyano-3-phenylprop-2-enoate |
| Molecular Formula | C12H12N2O2 |
| Purity | ≥95% |
| Target | Anti-infection |
| IUPAC Name | ethyl 3-amino-2-cyano-3-phenylprop-2-enoate |
| InChI | InChI=1S/C12H12N2O2/c1-2-16-12(15)10(8-13)11(14)9-6-4-3-5-7-9/h3-7H,2,14H2,1H3 |
| InChIKey | YKRQBWKLHCEKQH-UHFFFAOYSA-N |
| SMILES | CCOC(=O)C(=C(C1=CC=CC=C1)N)C#N |
